Dr. Amira Boseila | Neuroscience| Best Researcher Award

Lecturer at Sinai University,Egypt🎓

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

Professional Profile

Scopus Profile

🎓 Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

🏢 Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

🧬 Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors 🏆

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

🔬 Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

📚 Publication

Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis
Author: Amira Boseila
Citation: MDPI, 2023
Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
Author: Amira Boseila
Citation: ScienceDirect, 2024
Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
Author: Amira Boseila
Citation: Springer, 2022
Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
Author: Amira Boseila
Citation: MDPI, 2023
Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review
Author: Amira Boseila
Citation: NIH, 2023
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Author: Amira Boseila
Citation: PubMed, 2023
Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
Author: Amira Boseila
Citation: Molecular Pharmaceutics, 2023
Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles
Author: Amira Boseila
Citation: PubMed, 2023
Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile

ORCID

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

Publications :

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences